Logo
  • About
  • Contact
  • (888) 441-8033

GaN Systems Releases Highest Power Density 3kW LLC Reference Design for Power Applications

OTTAWA, Ontario, May 4, 2021 – GaN Systems, the global leader in GaN (gallium nitride) power semiconductors, today introduced a new reference design for a high density, high efficiency GaN-based 3kW LLC Resonant Converter (GS-EVB-LLC-3KW-GS) aimed to reduce design cycles, cost...

View full release

More than 2,000 Washington state residents expected to be diagnosed with bladder cancer in 2021

Bethesda, MD (May 3, 2021)—Although bladder cancer is the sixth most commonly diagnosed cancer in America, it is an underrecognized, yet very prevalent, disease that affects the more than 600,000 people in the U.S. living with it. To help shed light on this disease that more t...

View full release

For the People Announces First, Historic Youth, BIPOC Led “People’s Conference”

For the People, a political media organization that breaks down politics affecting people of color and young people, announced they will host the first ever “People’s Conference” in July 2022. Over the course of four days, a bipartisan, nationwide elected group of voters will ...

View full release

More than 500 Nebraskans expected to be diagnosed with bladder cancer in 2021

Bethesda, MD (May 3, 2021)—Although bladder cancer is the sixth most commonly diagnosed cancer in America, it is an underrecognized, yet very prevalent, disease that affects the more than 600,000 people in the U.S. living with it. To help shed light on this disease, May is Bla...

View full release

More than 3,000 Illinoisans expected to be diagnosed with bladder cancer in 2021

Bethesda, MD (May 3, 2021)—Although bladder cancer is the sixth most commonly diagnosed cancer in America, it is an underrecognized, yet very prevalent, disease that affects the more than 600,000 people in the U.S. living with it. To help shed light on this disease that more t...

View full release

More Than 2,000 Massachusetts Residents Expected to be Diagnosed with Bladder Cancer in 2021

Bethesda, MD (May 3, 2021)—Although bladder cancer is the sixth most commonly diagnosed cancer in America, it is an underrecognized, yet very prevalent, disease that affects the more than 600,000 people in the U.S. living with it. To help shed light on this disease that more t...

View full release

More than 4,200 Pennsylvanians expected to be diagnosed with bladder cancer in 2021

Bethesda, MD—Although bladder cancer is the sixth most commonly diagnosed cancer in America, it is an underrecognized, yet very prevalent, disease that affects the more than 600,000 people in the U.S. living with it. To help shed light on this disease that more than 83,000 peo...

View full release

More than 5,500 New Yorkers expected to be diagnosed with bladder cancer in 2021

Bethesda, MD (May 3, 2021)—Although bladder cancer is the sixth most commonly diagnosed cancer in America, it is an underrecognized, yet very prevalent, disease that affects the more than 600,000 people in the U.S. living with it. To help shed light on this disease that more t...

View full release

More than 2,600 North Carolinians expected to be diagnosed with bladder cancer in 2021

Bethesda, MD (May 3, 2021)—Although bladder cancer is the sixth most commonly diagnosed cancer in America, it is an underrecognized, yet very prevalent, disease that affects the more than 600,000 people in the U.S. living with it. To help shed light on this disease that more t...

View full release

More than 2,600 New Jerseyans expected to be diagnosed with bladder cancer in 2021

Bethesda, MD (May 3, 2021)—Although bladder cancer is the sixth most commonly diagnosed cancer in America, it is an underrecognized, yet very prevalent, disease that affects the more than 600,000 people in the U.S. living with it. To help shed light on this disease, May is Bla...

View full release
  • « First
  • ‹ Prev
  • …
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • …
  • Next ›
  • Last »
©2025 Reportable, Inc.
Terms and Conditions | Privacy Policy